Ultra-low Dose Oral Ketamine for Chronic Pain in the Primary Care Setting

Summary

This project is a pilot study to evaluate the analgesic and opioid-sparing effects of ketamine in an ultra-low dose oral formulation as a novel intervention for treatment of chronic non-cancer pain in opioid-tolerant patients in the primary care outpatient setting.

Timeline

Start

2014-11

Primary completion

2015-06

Completion

2015-06

Drugs

Indications